The intracranial pressure (ICP) monitoring devices are generally used for measuring the pressure developed between the brain and cranium caused by trauma or other reasons. These devices are used for monitoring the post-operative procedures among patients especially with skull injury and neurosurgery. Increasing brain and skull related accidents and trauma are fueling growth of the global intracranial pressure (ICP) monitoring market. As per the Centers for Disease Control and Prevention (CDC), in 2017, 30% of the injury deaths are attributable to traumatic brain injury in the U.S. Additionally, the market is likely to expand on the back of continuously improving technologies coupled with robust unmet need for novel medication globally. Thanks to these factors, the Intra-cranial Pressure Monitor Market is estimated to expand by exhibiting a CAGR of 7.1% during the forecast period from 2015 to 2024.
However, the factors, including the high costs involved in the intracranial pressure (ICP) monitoring devices and risks of recalls, are hampering the growth of the market. For instance, recently, in 2019, the U.S. Food and Drugs Administration (FDA) announced recall of Integra LifeSciences’ MoniTorr Intracranial Pressure (ICP) External CSF Drainage and Monitoring Systems and LimiTorr Volume Limiting Cerebrospinal Fluid (CSF) Drainage System. Nonetheless, factors such as increasing investment and continuous observation of newer devices and are offering breakthroughs to the most suitable devices, which are likely to provide robust opportunities for growth in the coming years.
GET FREE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/703
Some of the major companies in the global intracranial pressure (ICP) monitoring market include DePuy Synthes, Integra LifeSciences Corporation, Spiegelberg GmbH & Co. KG, Sophysa SA, RAUMEDIC Inc., Boston Neurosciences, Terumo Corporation, Medtronic Plc, and Natus Medical Incorporated.
The global intracranial pressure (ICP) monitoring market is segmented into technique, route of intervention, application, end user, device, region.
Based on the route of intervention, the market is segmented into epidural sensor, intraventricular, and others.
Based on the technique, the market has segmented into invasive and non-invasive. Of these, the invasive segment is further segmented into tympanic membrane displacement (TMD) analyzer, transcranial doppler ultrasonography, optic nerve sheath diameter sonography, MRI/CT, and fundoscopy (papilledema).
Based on the application, the intracranial pressure (ICP) monitoring market is segregated into subarachnoid hemorrhage, intracerebral hemorrhage, traumatic brain injury, meningitis, and others.
On the basis of the device, the market is segmented into subarachnoid screws, intraventricular catheters, fiber-optic monitors, non-invasive ICP monitors, and epidural sensors. Of these, the intraventricular catheter segment accounted for the largest market share in 2017 and reached a value of USD 559.1 million in the year and is likely to remain dominant by accounting revenue of USD 922.7 Million by 2024.
Based on the end user, the market is segmented into trauma centers, hospitals and clinics, and others. Of these, the hospitals and clinics segment are dominating the market and is projected to reach USD 1299.5 million by the end of 2024.
Regionally, the intracranial pressure (ICP) monitoring market is segmented intotheAmericas, Asia Pacific, Europe, and Middle East & Africa. Of these, the Americas region is estimated to hold the largest share in the revenue by the end of the forecast period by grabbing the value of USD 844.8 million by 2024 owing to increasing cases of trauma and skull injuries in the region. Additionally, Europe is estimated to hold a second leading position in 2017 owing to increasing investment for the adoption of advanced healthcare options in the region.
In 2019, Integra LifeSciences announced that it had acquired neurosurgical devices maker Arkis Biosciences. This way, Integra LifeSciences is taking steps toward the intracranial pressure (ICP) monitoring market.
In 2019, IRRAS AB announced that it had received regulatory approval for flagship product – IRRAflow from the Ministries of Health in Israel and Costa Rica.
Such product approvals, new launches, and new entrants in the market are estimated to fuel the global intracranial pressure (ICP) monitoring market.
Related Latest Trending Reports
About Market Research Future:
MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.